#indian-pharma-growth

India's Pharma Industry Set for Major Growth and Innovation in 2025

In 2025, the Indian pharmaceutical industry is set for a profound transformation driven by innovation, research excellence, and expanded global access. With the industry projected to reach USD 130 billion by 2030, India aims to become a global hub for high-quality, affordable pharmaceuticals, focusing on areas like CAR-T cell therapy, mRNA vaccines, and biosimilars. Technological advancements like AI, machine learning, and precision medicine are expected to revolutionize drug discovery, manuf

AI & Robotics

26 Dec 2024 06:13 AM

India's Pharma Industry Set for Major Growth and Innovation in 2025

In 2025, the Indian pharmaceutical industry is set for a profound transformation driven by innovation, research excellence, and expanded global access. With the industry projected to reach USD 130 billion by 2030, India aims to become a global hub for high-quality, affordable pharmaceuticals, focusing on areas like CAR-T cell therapy, mRNA vaccines, and biosimilars. Technological advancements like AI, machine learning, and precision medicine are expected to revolutionize drug discovery, manuf

AI & Robotics

Articles

Russia Ukraine war losses rise amid drone escalation

US proposes 5% remittance tax on non-citizens, Indians may face higher financial burden

China Bans Exports of Key Materials to U.S. Amid Escalating Trade Tensions

ITR Filing: Who Qualifies for Zero Income Tax Under New Rules

Driving Towards a Sustainable Future: The Rise of Electric Vehicles and Innovations

Best places to see tulips in the Netherlands this spring

Pawan-Revanth Maturity Defuses Telugu States Row

From Setback to Success: How to Restart and Rebuild Your Career

Beyond the Billion-Dollar Exit: Vinay Hiremath's Quest for Fulfillment

Modi Rejects Trump’s Mediation Claim on Kashmir Ceasefire

#indian-pharma-growth

India's Pharma Industry Set for Major Growth and Innovation in 2025

India's Pharma Industry Set for Major Growth and Innovation in 2025

Russia Ukraine war losses rise amid drone escalation

US proposes 5% remittance tax on non-citizens, Indians may face higher financial burden

China Bans Exports of Key Materials to U.S. Amid Escalating Trade Tensions

ITR Filing: Who Qualifies for Zero Income Tax Under New Rules

Driving Towards a Sustainable Future: The Rise of Electric Vehicles and Innovations

Best places to see tulips in the Netherlands this spring

Pawan-Revanth Maturity Defuses Telugu States Row

From Setback to Success: How to Restart and Rebuild Your Career

Beyond the Billion-Dollar Exit: Vinay Hiremath's Quest for Fulfillment

Modi Rejects Trump’s Mediation Claim on Kashmir Ceasefire

Popular Cities

Sign In

Russia Ukraine war losses rise amid drone escalation

US proposes 5% remittance tax on non-citizens, Indians may face higher financial burden

China Bans Exports of Key Materials to U.S. Amid Escalating Trade Tensions

ITR Filing: Who Qualifies for Zero Income Tax Under New Rules

Driving Towards a Sustainable Future: The Rise of Electric Vehicles and Innovations

Best places to see tulips in the Netherlands this spring

Pawan-Revanth Maturity Defuses Telugu States Row

From Setback to Success: How to Restart and Rebuild Your Career

Beyond the Billion-Dollar Exit: Vinay Hiremath's Quest for Fulfillment

Modi Rejects Trump’s Mediation Claim on Kashmir Ceasefire

#indian-pharma-growth

India's Pharma Industry Set for Major Growth and Innovation in 2025

India's Pharma Industry Set for Major Growth and Innovation in 2025

Russia Ukraine war losses rise amid drone escalation

US proposes 5% remittance tax on non-citizens, Indians may face higher financial burden

China Bans Exports of Key Materials to U.S. Amid Escalating Trade Tensions

ITR Filing: Who Qualifies for Zero Income Tax Under New Rules

Driving Towards a Sustainable Future: The Rise of Electric Vehicles and Innovations

Best places to see tulips in the Netherlands this spring

Pawan-Revanth Maturity Defuses Telugu States Row

From Setback to Success: How to Restart and Rebuild Your Career

Beyond the Billion-Dollar Exit: Vinay Hiremath's Quest for Fulfillment

Modi Rejects Trump’s Mediation Claim on Kashmir Ceasefire

Popular Cities